Prognostic factors in colorectal cancer - Literature review for clinical application

被引:122
作者
Ratto, C [1 ]
Sofo, L [1 ]
Ippoliti, N [1 ]
Merico, M [1 ]
Doglietto, GB [1 ]
Crucitti, F [1 ]
机构
[1] Catholic Univ, Dept Clin Chirurg, I-00168 Rome, Italy
关键词
colorectal cancer; prognosis; survival; tumor stage; lymph node involvement; distant metastases; bowel obstruction; univariate analysis; multivariate analysis;
D O I
10.1007/BF02237397
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: Identification of prognostic factors is a primary basis for planning the treatment and predicting the outcome of patients with colorectal cancer. Reviewing studies from the literature performed using univariate and multivariate analyses and their own study, the authors critically discuss the prognostic value of the clinicopathologic parameters of the tumor. METHODS: Among 853 patients with colorectal tumors seen at the Department of Clinical Surgery of the Catholic University of Rome, Italy, 690 cases that were curatively resected entered the study. Overall survival rate, related to the clinicopathologic variables, was calculated, and univariate and multivariate analyses were per formed. RESULTS: Five-year and ten-year overall survival rates were 70 and 55 percent, respectively. Univariate and multivariate analyses showed that node involvement, distant metastases, bowel obstruction, and patient gender are factors independently related to outcome. CONCLUSIONS: Data from the literature and the present study suggest that only a few clinical parameters, particularly bowel obstruction, and some pathologic factors (tumor stage, vessels invasion, and tumor ploidy) are related to patient survival rate and are the most reliable prognostic criteria. In prospective clinical studies, any other new pathologic or molecular factors should be matched with these parameters to confirm their value in outcome prediction.
引用
收藏
页码:1033 / 1049
页数:17
相关论文
共 158 条
  • [1] CARCINOEMBRYONIC ANTIGEN (CEA) AND ALKALINE-PHOSPHATASE IN PROGRESSIVE COLORECTAL-CANCER WITH SPECIAL REFERENCE TO PATIENT SURVIVAL
    AABO, K
    PEDERSEN, H
    KJAER, M
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (02): : 211 - 217
  • [2] AALTONEN LA, 1994, CANCER RES, V54, P1645
  • [3] CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER
    AALTONEN, LA
    PELTOMAKI, P
    LEACH, FS
    SISTONEN, P
    PYLKKANEN, L
    MECKLIN, JP
    JARVINEN, H
    POWELL, SM
    JEN, J
    HAMILTON, SR
    PETERSEN, GM
    KINZLER, KW
    VOGELSTEIN, B
    DELACHAPELLE, A
    [J]. SCIENCE, 1993, 260 (5109) : 812 - 816
  • [4] ALBE X, 1990, CANCER, V66, P1168, DOI 10.1002/1097-0142(19900915)66:6<1168::AID-CNCR2820660616>3.0.CO
  • [5] 2-I
  • [6] BAND PR, 1977, CAN MED ASSOC J, V117, P657
  • [7] PROGNOSTIC VALUE OF P53 OVEREXPRESSION AND C-KI-RAS GENE-MUTATIONS IN COLORECTAL-CANCER
    BELL, SM
    SCOTT, N
    CROSS, D
    SAGAR, P
    LEWIS, FA
    BLAIR, GE
    TAYLOR, GR
    DIXON, MF
    QUIRKE, P
    [J]. GASTROENTEROLOGY, 1993, 104 (01) : 57 - 64
  • [8] CLINICAL-SIGNIFICANCE OF THE PREOPERATIVE PLASMA CARCINOEMBRYONIC ANTIGEN (CEA) LEVEL IN PATIENTS WITH CARCINOMA OF THE LARGE BOWEL
    BLAKE, KE
    DALBOW, MH
    CONCANNON, JP
    HODGSON, SE
    BRODMERKEL, GJ
    PANAHANDEH, AH
    ZIMMERMAN, K
    HEADINGS, JJ
    [J]. DISEASES OF THE COLON & RECTUM, 1982, 25 (01) : 24 - 32
  • [9] PREVALENCE OF RAS GENE-MUTATIONS IN HUMAN COLORECTAL CANCERS
    BOS, JL
    FEARON, ER
    HAMILTON, SR
    VERLAANDEVRIES, M
    VANBOOM, JH
    VANDEREB, AJ
    VOGELSTEIN, B
    [J]. NATURE, 1987, 327 (6120) : 293 - 297
  • [10] BOS JL, 1989, CANCER RES, V49, P4682